对COVID-19后认知障碍认知康复干预的初步评估:试点随机对照试验
Jacqueline H Becker1, Eric Watson2, Nadia Zubair1
1Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Neuropsychological rehabilitation
|September 24, 2025
概括
认知康复 (CR) 可能有助于改善长期COVID脑雾和认知问题. 这项试点研究显示,与对照组相比,接受适应CR干预的人对认知功能有自我报告的改善.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 传染性疾病 传染性疾病
背景情况:
- 长期COVID经常导致显著的认知障碍,通常被称为"脑雾",特别是在年轻人中.
- 目前,对于COVID后的认知缺陷没有确立有效的干预措施.
- 这项研究解决了急需有效治疗SARS-CoV-2感染后认知障碍的迫切需要.
研究的目的:
- 调查针对COVID-19后经历认知障碍的人士量身定制的认知康复 (CR) 计划的初步疗效.
- 评估CR对认知功能客观和主观测量的影响.
主要方法:
- 一项试点随机对照试验与18岁以上的参与者进行,这些参与者有SARS-CoV-2感染史和确诊的认知障碍.
- 参与者被随机分配到12周的CR干预组或时间和注意力匹配的对照组.
- 在干预前和干预后两周内使用验证的神经心理测试来评估认知功能.
主要成果:
- 与对照组相比,CR干预组在处理速度,学习,记忆,语言和执行功能的测量方面没有显示任何徒劳的迹象.
- 与对照组相比,CR干预组的参与者报告说,他们的认知功能在主观上有显著的改善.
结论:
- 一种适应的认知康复干预措施显示,它有望改善与长期COVID相关的认知障碍.
- 这些发现支持需要进行更大规模的,最终的试验,以进一步评估CR对COVID后认知缺陷的疗效.
更多相关视频
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.9K
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
1.6K
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
